A 104-Week Delayed-Start Analysis of PASADENA (Phase II Study Evaluating the Safety and Efficacy of Prasinezumab in Early-Stage Parkinson's Disease)
Gennaro Pagano,Stefano Zanigni,Annabelle Monnet,Kirsten I. Taylor,Andrea Hahn,Kenneth Marek, Ron Postuma,Nicola Pavese,Fabrizio Stocchi,Tanya Simuni,Giulia D'Urso,Nathalie Pross,Michael Lindemann,Hanno Svoboda,Paulo Fontoura,Rachelle Doody,Geoffrey A. Kerchner,Azad Bonni,Tania Nikolcheva MOVEMENT DISORDERS（2022）
AI 理解论文
溯源树
样例
